Transcriptional_JJ
targeting_NN
of_IN
retroviral_JJ
vectors_NNS
to_TO
the_DT
erythroblastic_JJ
progeny_NN
of_IN
transduced_VBN
hematopoietic_JJ
stem_NN
cells_NNS
._.

Targeted_VBN
expression_NN
to_TO
specific_JJ
tissues_NNS
or_CC
cell_NN
lineages_NNS
is_VBZ
a_DT
necessary_JJ
feature_NN
of_IN
a_DT
gene_NN
therapy_NN
vector_NN
for_IN
many_JJ
clinical_JJ
applications_NNS
,_,
such_JJ
as_IN
correction_NN
of_IN
hemoglobinopathies_NNS
or_CC
thalassemias_NNS
by_IN
transplantation_NN
of_IN
genetically_RB
modified_VBN
hematopoietic_JJ
stem_NN
cells_NNS
._.

We_PRP
developed_VBD
retroviral_JJ
vectors_NNS
in_IN
which_WDT
the_DT
constitutive_JJ
viral_JJ
enhancer_NN
in_IN
the_DT
U3_NN
region_NN
of_IN
the_DT
3_CD
'_POS
LTR_NN
is_VBZ
replaced_VBN
by_IN
an_DT
autoregulatory_JJ
enhancer_NN
of_IN
the_DT
erythroid-specific_JJ
GATA-1_NN
transcription_NN
factor_NN
gene_NN
._.

The_DT
replaced_VBN
enhancer_NN
is_VBZ
propagated_VBN
to_TO
the_DT
5_CD
'_POS
LTR_NN
upon_IN
integration_NN
into_IN
the_DT
target_NN
cell_NN
genome_NN
._.

The_DT
modified_VBN
vectors_NNS
were_VBD
used_VBN
to_TO
transduce_VB
human_JJ
hematopoietic_JJ
cell_NN
lines_NNS
,_,
cord_NN
blood-derived_JJ
CD34_NN
-LRB-_-LRB-
+_NN
-RRB-_-RRB-
stem\/progenitor_NN
cells_NNS
,_,
and_CC
murine_JJ
bone_NN
marrow_NN
repopulating_JJ
stem_NN
cells_NNS
._.

The_DT
expression_NN
of_IN
appropriate_JJ
reporter_NN
genes_NNS
-LRB-_-LRB-
triangle_NN
upLNGFR_NN
,_,
EGFP_NN
-RRB-_-RRB-
was_VBD
analyzed_VBN
in_IN
the_DT
differentiated_VBN
progeny_NN
of_IN
transduced_VBN
stem_NN
cells_NNS
in_FW
vitro_FW
,_,
in_IN
liquid_JJ
culture_NN
as_RB
well_RB
as_IN
in_IN
clonogenic_JJ
assay_NN
,_,
and_CC
in_FW
vivo_FW
,_,
after_IN
bone_NN
marrow_NN
transplantation_NN
in_IN
lethally_RB
irradiated_JJ
mice_NNS
._.

The_DT
GATA-1_NN
autoregulatory_JJ
enhancer_NN
effectively_RB
restricts_VBZ
the_DT
expression_NN
of_IN
the_DT
LTR-driven_JJ
proviral_JJ
transcription_NN
unit_NN
to_TO
the_DT
erythroblastic_JJ
progeny_NN
of_IN
both_CC
human_JJ
progenitors_NNS
and_CC
mouse-repopulating_JJ
stem_NN
cells_NNS
._.

Packaging_NN
of_IN
viral_JJ
particles_NNS
,_,
integration_NN
into_IN
the_DT
target_NN
genome_NN
,_,
and_CC
stability_NN
of_IN
the_DT
integrated_JJ
provirus_NN
are_VBP
not_RB
affected_VBN
by_IN
the_DT
LTR_NN
modification_NN
._.

Enhancer_NN
replacement_NN
is_VBZ
therefore_RB
an_DT
effective_JJ
strategy_NN
to_TO
target_NN
expression_NN
of_IN
a_DT
retroviral_JJ
transgene_NN
to_TO
a_DT
specific_JJ
progeny_NN
of_IN
transduced_VBN
hematopoietic_JJ
stem_NN
cells_NNS
._.

